Trial Profile
The Effects of Nitric Oxide for Inhalation on Survival or the Need for Dialysis or a Right Ventricular Assistance Device (RVAD) in Right Ventricular Infarction Patients
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Nitric oxide (Primary)
- Indications Myocardial infarction
- Focus Therapeutic Use
- Sponsors Ikaria Holdings; INO Therapeutics
- 23 Nov 2008 New trial record.